Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1094P, also known as RNA, U6 small nuclear 1094, pseudogene, is a pseudogene related to the U6 small nuclear RNA (snRNA) gene family. U6 snRNA is a crucial component of the major spliceosome, participating in pre-mRNA splicing in eukaryotes[1][3]. However, as a "pseudogene" of U6 snRNA, RNU6-1094P does not produce a functional RNA product and lacks protein-coding capacity. Pseudogenes were historically considered "junk DNA," but accumulating evidence indicates that some pseudogenes can be transcribed and may participate in gene regulation as competitive endogenous RNAs, or even give rise to regulatory small RNAs such as siRNAs[2]. There is currently no direct evidence that RNU6-1094P itself is functionally active or disease-associated. RNU6-1094P is not recognized as a therapeutic target, nor is it known to interact with drugs or serve as a biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1094, pseudogene (RNU6-1094P).